Mérieux Equity Partners

← Back to your selection

All recorded activity

Rounds participated in: 2
Confirmed lead rounds: 1
New companies: 2
Funding in participating rounds: $101.3M

By stage

Series A1

Undisclosed1

By primary sector

Biotech1

Healthtech1

By country

Belgium1

France1

Rounds

2 in all activity

Sep 22

HighLife

HighLife Medical develops a transcatheter mitral-valve replacement system designed to treat patients with severe mitral regurgitation without open-heart surgery.

€80MFinancing round

Lead

Sep 1

Amyl Therapeutics

Amyl Therapeutics is developing immunotherapies that target amyloid aggregates linked to neurodegenerative disease.

€8.3MSeries A extension

Participant